A groundbreaking new study has offered the most detailed look yet at the genetic changes behind colorectal cancer—one of the most common and deadly cancers in the world. This research brings scientists a big step closer to understanding how the disease starts, how it grows, and how to treat it more effectively.
Led by top researchers from the UK, including teams from The Institute of Cancer Research in London, the University of Oxford, and the University of Manchester, the study used data from 2,023 samples of colorectal cancer. These samples were part of the large 100,000 Genomes Project, which collects genetic information from people with different diseases across England.
Colorectal cancer happens when cells in the colon or rectum (parts of the large intestine) begin to grow out of control. This happens because of changes, or mutations, in the DNA inside the cells. But until now, scientists didn’t fully understand which genes were involved or how these changes led to cancer.
This new research, published in the journal Nature, changes that. The scientists found more than 250 genes that play important roles in colorectal cancer. Many of these had never been linked to cancer before. These genes affect how cancer cells grow, how they escape the immune system, and how they might respond to drugs.
The study also identified four common sub-groups of colorectal cancer, along with some rare ones. Each group has a unique genetic profile. This is important because it shows that not all colorectal cancers are the same.
Some types may be more aggressive, while others might respond better to specific treatments. Knowing the genetic makeup of each tumor could help doctors personalize treatment for each patient.
One especially important finding was that different parts of the colon and rectum may have different kinds of genetic mutations. This helps explain why the disease can vary so much from person to person.
For example, researchers found a process that seems more active in younger patients’ tumors. Although the cause isn’t clear, it may be influenced by lifestyle factors like diet and smoking.
The study also found that some of the mutations could potentially be treated using drugs already available for other cancers. This means that patients with certain genetic changes might benefit from treatments that are not currently used for colorectal cancer—but could be.
Another exciting part of the study looked at the gut microbiome, the mix of bacteria and viruses that live in our digestive system. Researchers sequenced the microbiomes of colorectal cancer patients in detail for the first time. This opens up the possibility of using gut bacteria as a new way to understand or even treat the disease in the future.
The research team hopes that these discoveries will lead to better tools for predicting how cancer will behave and how it will respond to treatment. They also hope it will spark more studies into new drugs and personalized therapies.
Professor Ian Tomlinson from the University of Oxford, one of the study’s lead researchers, said that a deeper understanding of the genes behind colorectal cancer could help doctors choose the best treatments and improve patients’ chances of survival.
Professor Richard Houlston from The Institute of Cancer Research added that the study gives us vital clues about how colorectal cancer starts and grows, and how it might be stopped.
Professor David Wedge from the University of Manchester emphasized that this is one of the first major results from the 100,000 Genomes Project, and that many more discoveries about different types of cancer are likely to follow.
Dr. Henry Wood from the University of Leeds added that exploring the gut microbiome alongside the tumor’s DNA gives scientists a fuller picture of what’s happening in the body—and could offer new ways to fight cancer.
In short, this massive study helps explain why colorectal cancer develops, why it’s so different from person to person, and how we might finally find better ways to treat it. For patients and researchers alike, it’s a hopeful step forward in the fight against one of the world’s deadliest diseases.
If you care about cancer, please read studies about a new method to treat cancer effectively, and this low-dose, four-drug combo may block cancer spread.
For more information about cancer prevention, please see recent studies about nutrient in fish that can be a poison for cancer, and results showing this daily vitamin is critical to cancer prevention.
Copyright © 2025 Knowridge Science Report. All rights reserved.
